You are here » Home » Companies » Company Overview » Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd.

BSE: 524663 Sector: Health care
NSE: N.A. ISIN Code: INE994B01014
BSE LIVE 15:51 | 16 Jan 23.30 0
(0.00%)
OPEN

22.80

HIGH

24.00

LOW

22.80

NSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 22.80
PREVIOUS CLOSE 23.30
VOLUME 35002
52-Week high 27.80
52-Week low 16.65
P/E 70.61
Mkt Cap.(Rs cr) 100.61
Buy Price 23.30
Buy Qty 200.00
Sell Price 0.00
Sell Qty 0.00
OPEN 22.80
CLOSE 23.30
VOLUME 35002
52-Week high 27.80
52-Week low 16.65
P/E 70.61
Mkt Cap.(Rs cr) 100.61
Buy Price 23.30
Buy Qty 200.00
Sell Price 0.00
Sell Qty 0.00

Bharat Immunological & Biological Corporation Ltd. (BHARATIMMUNOLOG) - Company History

Incorporated in 1989 in Uttar Pradesh, Bharat Immunological & Biological Corporation (BIBCL) is in the business of manufacturing pharmaceutical formulations. The company's manufacturing unit is located in Bulandshahr district, Uttar Pradesh. BIBCL manufactures oral polio vaccine (OPV) for which it has installed a plant of 100 mln units. Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme. It has set up an R&D unit for the development of hepatitis B vaccine through transfer of technology from the US. The Company is planning to diversify into the production of vaccines pertaining to B.C.G, Measles and Tetanus Toxide.The company has been declared a SICK company by BIFR.